Conversely, genetic depletion or pharmacological inhibition of SCD decreases acute lymphoblastic leukemia (ALL) burden in the central nervous system, but has no effect or increases leukemia burden in the bone marrow while the effects on survival were not studied [13]. This evidence concerns the gene SCD and acute lymphoblastic leukemia.